Browse by author
Lookup NU author(s): Tristan Reuillon, Duncan MillerORCiD, Stephanie Myers, Dr Lauren Molyneux, Dr Celine CanoORCiD, Dr Ian HardcastleORCiD, Professor Roger Griffin, Dr Laurent Rigoreau, Emeritus Professor Bernard Golding, Professor Martin NobleORCiD
Full text is not currently available for this publication.
The invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the prophylaxis or treatment of a disease state or condition mediated by ERK5, in particular cancers
Inventor(s): Reuillon T, Miller D, Myers S, Molyneux L, Cano C, Hardcastle I, Griffin R, Rigoreau L, Golding B, Noble M
Publication type: Patent
Publication status: Published
Year: 2016
Print publication date: 24/03/2016
Acceptance date: 24/03/2016